BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25903567)

  • 1. Changes in MMP-9 and TIMP-1 Concentrations in Cerebrospinal Fluid after 1 Week of Treatment of Childhood Bacterial Meningitis.
    Roine I; Pelkonen T; Lauhio A; Lappalainen M; Cruzeiro ML; Bernardino L; Tervahartiala T; Sorsa T; Peltola H
    J Clin Microbiol; 2015 Jul; 53(7):2340-2. PubMed ID: 25903567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of cerebrospinal fluid matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 concentrations in childhood bacterial meningitis.
    Roine I; Pelkonen T; Bernardino L; Lauhio A; Tervahartiala T; Lappalainen M; Kataja M; Pitkäranta A; Sorsa T; Peltola H
    Pediatr Infect Dis J; 2014 Jul; 33(7):675-9. PubMed ID: 24445831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
    Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
    Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of children with echovirus type 30 and mumps meningitis.
    Sulik A; Wojtkowska M; Oldak E
    Scand J Immunol; 2008 Sep; 68(3):323-7. PubMed ID: 18565120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis.
    Ichiyama T; Matsushige T; Siba P; Suarkia D; Takasu T; Miki K; Furukawa S
    J Infect; 2008 May; 56(5):376-80. PubMed ID: 18395263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers.
    Lezin A; Buart S; Smadja D; Akaoka H; Bourdonné O; Perret-Liaudet A; Césaire R; Belin MF; Giraudon P
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):965-72. PubMed ID: 10890358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of purulent meningitis on the changes of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase inhibitor-1 (TIMP-1) in cerebrospinal fluid of neonates.
    Cui W; Luo X; Zhang Y
    Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2437-2441. PubMed ID: 31894031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes of matrix metalloproteinase-9 in patients with Klebsiella pneumoniae meningitis.
    Tsai HC; Liu SF; Wu KS; Liu YC; Shi MH; Chen ER; Yen CM; Lee SS; Huang YL; Chen YS
    Inflammation; 2008 Aug; 31(4):247-53. PubMed ID: 18553165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swiftly Decreasing Cerebrospinal Fluid Cathelicidin Concentration Predicts Improved Outcome in Childhood Bacterial Meningitis.
    Savonius O; Helve O; Roine I; Andersson S; Fernández J; Peltola H; Pelkonen T
    J Clin Microbiol; 2016 Jun; 54(6):1648-1649. PubMed ID: 27008883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
    Matsuura E; Umehara F; Hashiguchi T; Fujimoto N; Okada Y; Osame M
    J Neurol Sci; 2000 Feb; 173(1):45-52. PubMed ID: 10675579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Role of Matrix Metalloproteinases 8 and 9 and Myeloperoxidase in Predicting Outcomes of Bacterial Meningitis of Childhood.
    Savonius O; Roine I; Alassiri S; Tervahartiala T; Helve O; Fernández J; Peltola H; Sorsa T; Pelkonen T
    Mediators Inflamm; 2019; 2019():7436932. PubMed ID: 31780869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Niebroj-Dobosz I; Janik P; Sokołowska B; Kwiecinski H
    Eur J Neurol; 2010 Feb; 17(2):226-31. PubMed ID: 19796283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinase-4 in cerebrospinal fluid with blood-brain barrier dysfunction in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis.
    Tsai HC; Chung LY; Chen ER; Liu YC; Lee SS; Chen YS; Sy CL; Wann SR; Yen CM
    Am J Trop Med Hyg; 2008 Jan; 78(1):20-7. PubMed ID: 18187780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.
    Lindberg RL; Sorsa T; Tervahartiala T; Hoffmann F; Mellanen L; Kappos L; Schaad UB; Leib SL; Leppert D
    Neuropathol Appl Neurobiol; 2006 Jun; 32(3):304-17. PubMed ID: 16640649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis.
    Beuche W; Yushchenko M; Mäder M; Maliszewska M; Felgenhauer K; Weber F
    Neuroreport; 2000 Nov; 11(16):3419-22. PubMed ID: 11095490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Matrix Metalloproteinase Concentrations Offer Novel Insight Into Their Role in Pediatric Tuberculous Meningitis.
    Li YJ; Wilkinson KA; Wilkinson RJ; Figaji AA; Rohlwink UK
    J Pediatric Infect Dis Soc; 2020 Feb; 9(1):82-86. PubMed ID: 30753686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing-remitting multiple sclerosis treated with interferon beta.
    Boz C; Ozmenoglu M; Velioglu S; Kilinc K; Orem A; Alioglu Z; Altunayoglu V
    Clin Neurol Neurosurg; 2006 Feb; 108(2):124-8. PubMed ID: 16412833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of MMP-9 and TIMP-1 in the cerebrospinal fluid of neuro-Behçet's disease.
    Hamzaoui K; Maître B; Hamzaoui A
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S52-7. PubMed ID: 19796534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Title: role of matrix metalloproteinase -9 in progression of tuberculous meningitis: a pilot study in patients at different stages of the disease.
    Majeed S; Singh P; Sharma N; Sharma S
    BMC Infect Dis; 2016 Nov; 16(1):722. PubMed ID: 27899068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in tissues with a diagnosis of childhood lymphoma.
    Bozkurt C; Ertem U; Oksal A; Sahin G; Yüksek N; Birgen D
    Pediatr Hematol Oncol; 2008 Sep; 25(7):621-9. PubMed ID: 18850474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.